Growth of benign and malignant schwannoma xenografts in severe combined immunodeficiency mice

Laryngoscope

Volumn 116, Issue 11, 2006, Pages 2018-2026

  Chang, Long Sheng ^a,b,c   Abraham, Jacob ^a   Lorenz, Mark ^b   Rock, Jonathan ^b   Akhmametyeva, Elena M ^a,c   Mihai, Georgeta ^a   Schmalbrock, Petra ^a,b   Chaudhury, Abhik R ^a,b   Lopez, Raul ^b   Yamate, Jyoji ^d   John, Markus R ^e   Wickert, Hannes ^f   Neff, Brian A ^a   Dodson, Edward ^a,b   Welling, D Bradley ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b BAYLOR UNIVERSITY   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d Osaka Prefecture University   (Japan)

^e NOVARTIS PHARMA AG   (Switzerland)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cystic; Gadolinium; Magnetic resonance imaging (MRI); Malignant; Neurofibromatosis type 2 (NF2); Severe combined immunodeficiency (SCID) mice; Vestibular schwannoma; Xenograft

Indexed keywords

ACOUSTIC NEURINOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMPLANTATION; KNOCKOUT MOUSE; MALIGNANT NEURILEMOMA; MICROSCOPY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; SCID MOUSE; TRANSGENIC MOUSE; TUMOR CELL; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MICE; MICE, SCID; NEUROMA, ACOUSTIC; TRANSPLANTATION, HETEROLOGOUS;

EID: 33750685043     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000240185.14224.7d     Document Type: Article

References (21)

1. Neff BA, Welling DB, Akhmametyeva E, Chang L-S. The molecular biology of vestibular schwannomas: dissecting the pathogenic process at the molecular level. Otol Neurotol 2006;27:197-208.
2. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organising protein causes neurofibromatosis type 2. Nature 1993;363:515-521.
3. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel Moesin-, Exrin-, Radixin-like gene is a candidate for the neurofibromatosis 2 tumor-suppressor. Cell 1993;72:791-800.
4. Charabi S, Klinken L, Tos M, Thomsen J. Histopathology and growth pattern of cystic acoustic neuromas. Laryngoscope 1994;104:1348-1352.
5. Fundova P, Charabi S, Tos M, Thomsen J. Cystic vestibular schwannoma: surgical outcome. J Laryngol Otol 2000;114:935-939.
6. Welling DB, Lasak JM, Akhmametyeva EM, Chang L-S. cDNA microarray analysis of vestibular schwannomas. Otol Neurotol 2002;23:736-748.
7. Shin M, Ueki K, Kurita H, Kirino T. Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery. Lancet 2002;360:309-310.
8. Niemczyk K, Vaneecloo FN, Lecomte MH, et al. Correlation between Ki-67 index and some clinical aspects of acoustic neuromas (vestibular schwannomas). Otolaryngol Head Neck Surg 2000;123:779-783.
9. Lee JK, Sobel RA, Chiocca EA, Kim TS, Martuza RL. Growth of human acoustic neuromas, neurofibromas and schwannomas in the subrenal capsule and sciatic nerve of the nude mouse. J Neurooncol 1992;14:101-112.
10. Charabi S, Rygaard J, Klinken L, Tos M, Thomsen J. Subcutaneous growth of human acoustic schwannomas in athymic nude mice. Acta Otolaryngol 1994;114:399-405.
11. Stidham KR, Roberson JB Jr. Human vestibular schwannoma growth in the nude mouse: evaluation of a modified subcutaneous implantation model. Am J Otol 1997;18:622-626.
12. Yamate J, Yasui H, Benn SJ, et al. Characterization of newly established tumor lines from a spontaneous malignant schwannoma in F344 rats: nerve growth factor production, growth inhibition by transforming growth factor-β1, and macrophage-like phenotype expression. Acta Neuropathol (Berl) 2003;106:221-233.
13. Imada M, Sueoka N. Clonal sublines of rat neurotumor RT4 and cell differentiation. I. Isolation and characterization of cell lines and cell type conversion. Dev Biol 1978;66:97-108.
14. John MR, Wickert H, Zaar K, et al. A case of neuroendocrine oncogenic osteomalacia associated with a PHEX and fibroblast growth factor-23 expressing sinusidal malignant schwannoma. Bone 2001;29:393-402.
15. Charabi S, Simonsen K, Charabi B, et al. Nerve growth factor receptor expression in heterotransplanted vestibular schwannoma in athymic nude mice. Acta Otolaryngol 1996;116:59-63.
16. Giovannini M, Robanus-Maandag E, Niwa-Kawakita M, et al. Schwann cell hyperplasia and tumors in transgenic mice expressing a naturally occurring mutant NF2 protein. Genes Dev 1999;13:978-986.
17. Giovannini M, Robanus-Maandag E, van der Valk M, et al. Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev 2000;14:1617-1630.
18. Hung G, Colton J, Fisher L, et al. Immunohistochemistry study of human vestibular nerve schwannoma differentiation. Glia 2002;38:363-370.
19. Ona A. The mammalian vestibular ganglion cells and the myelin sheath surrounding them. Acta Otolaryngol Suppl 1993;503:143-149.
20. Stemmer-Rachamimov AO, Louis DN, Nielsen GP, et al. Comparative pathology of nerve sheath tumors in mouse models and humans. Cancer Res 2004;64:3718-3724.
21. Hung G, Li X, Faudoa R, et al. Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2. Int J Oncol 2002;20:475-482.